SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to positive Phase 3 trial results for its Duchenne muscular dystrophy treatment, deramiocel, showing statistically significant benefits. Community discussions highlight H.C. Wainwright's upgraded price target and the potential for a short squeeze, with some expressing gratitude for long-term holders' DD. The focus remains on the company's strong cash position and the potential for FDA approval, which could significantly impact the treatment landscape for DMD.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing ($BA) is trending as investors digest news of the company's CFO projecting positive free cash flow by 2026 and increased jet deliveries. Community members are actively debating whether this news justifies the recent price surge, with some expressing skepticism and others anticipating a continued rally towards higher price targets. Discussions also involve the impact of new defense contracts and production improvements.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending due to refuted reports of lowered AI sales quotas, sparking debate about the company's AI prospects and market manipulation. The community is discussing the validity of the news, potential recovery, and its impact on long-term investment strategies. Some are concerned about the manipulation surrounding MSFT and OpenAI, while others see the dip as a buying opportunity.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors discuss a potential breakout leading up to the upcoming earnings report, with some highlighting a large purchase of shares and speculating about the buyer. Community members are debating the significance of the recent volume and its impact on price movement, while others are focusing on warrant activity. Many continue to express strong conviction in the stock's long-term potential.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as the community anticipates FDA feedback on submitted data for belapectin by year-end, potentially influencing the drug's future. Community sentiment is largely positive, with many expressing confidence in the science and speculating about a potential buyout or partnership. Investors are actively monitoring short positions and institutional activity, suggesting anticipation of a significant market move.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana ($CVNA) is trending due to a recent surge in price, fueled by analyst upgrades and short squeezes, despite ongoing discussions about the company's fundamentals and potential market manipulation. Community members are debating the sustainability of the rally, with some pointing to insider selling and high valuation metrics, while others highlight the potential for further gains. The stock's unusual price action and controversial business practices continue to be hot topics among investors.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as investors eagerly await news on the NASA Lunar Terrain Vehicle (LTV) contract award, with some speculating an announcement is imminent. Community discussions also highlight a recent insider buy and the company's acquisition of Lanteris Space Systems, contributing to bullish sentiment despite market volatility and concerns about short interest. Some are looking ahead to future catalysts, such as the IM-3 mission.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid ongoing speculation and bidding wars with Warner Bros. Discovery ($WBD), with investors assessing the potential impact of a deal. The community is actively debating whether acquiring $WBD would be a positive move, and whether the company should focus on organic growth instead.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as the community analyzes recent price action and upcoming earnings, with discussions focusing on potential resistance levels and future growth catalysts. Bullish sentiment appears to be building, driven by optimism surrounding AI infrastructure and data center revenue, and target price increases. Some traders are cautious, noting the stock's historical volatility around earnings and recent analyst ratings.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics ($SERV) is trending amid community excitement surrounding its growth potential in the robotics sector, spurred by upcoming earnings and its partnerships with Uber Eats and DoorDash. Discussions highlight anticipation for the company to deploy 2,000 robots by the end of the year and achieve substantial revenue growth in 2026, with some traders noting potential government support for the robotics industry as a further catalyst. The stock is viewed by some as undervalued with considerable long-term potential, while others express concerns about recent price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Magnetar Financial LLC Buys 64,345 Shares of Kura Oncology, Inc. $KURA

Magnetar Financial LLC grew its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 536.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...

Interesting KURA Put And Call Options For July 2026

Investors in Kura Oncology Inc (Symbol: KURA) saw new options begin trading this week, for the July 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay...

Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the fifteen research firms that are covering the firm, Marketbeat Ratings...

Los Angeles Capital Management LLC Acquires Shares of 77,958 Kura Oncology, Inc. $KURA

Los Angeles Capital Management LLC purchased a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the second quarter, according to the company in its most recent Form...

Savant Capital LLC Increases Position in Kura Oncology, Inc. $KURA

Savant Capital LLC increased its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 74.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange...

Insider Selling: Kura Oncology (NASDAQ:KURA) SVP Sells 4,539 Shares of Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) SVP Thomas James Doyle sold 4,539 shares of the company's stock in a transaction that occurred on Friday, November 14th. The shares were sold at an...

Kathleen Ford Sells 6,902 Shares of Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) COO Kathleen Ford sold 6,902 shares of the firm's stock in a transaction dated Friday, November 14th. The shares were sold at an average price of...

Teresa Brophy Bair Sells 8,804 Shares of Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Teresa Brophy Bair sold 8,804 shares of the business's stock in a transaction that occurred on Friday, November 14th. The shares were sold...

Kura Oncology (NASDAQ:KURA) Insider Brian Powl Sells 8,887 Shares

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Brian Powl sold 8,887 shares of the firm's stock in a transaction dated Friday, November 14th. The shares were sold at an average price of...

Kura Oncology (NASDAQ:KURA) Insider Mollie Leoni Sells 15,485 Shares

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Mollie Leoni sold 15,485 shares of Kura Oncology stock in a transaction that occurred on Friday, November 14th. The stock was sold at an...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

KURA
Kura Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KURA News

KURAKura Oncology Inc